Filing Details

Accession Number:
0001214659-20-010294
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-09 17:11:12
Reporting Period:
2020-12-07
Accepted Time:
2020-12-09 17:11:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581280 Twist Bioscience Corp TWST () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219039 Keith Crandell 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-18 685,613 $0.00 1,721,809 No 4 J Indirect By Arch Venture Fund VII, L.P.
Common Stock Acquisiton 2020-08-18 34,845 $0.00 34,845 No 4 J Indirect By Keith L.Crandall Trust
Common Stock Disposition 2020-08-18 248,083 $0.00 706,063 No 4 J Indirect By ARCH Venture Fund VIII Overage, L.P.
Common Stock Acquisiton 2020-08-18 3 $0.00 34,848 No 4 J Indirect By Keith L.Crandall Trust
Common Stock Disposition 2020-09-02 497,032 $0.00 1,224,777 No 4 J Indirect By Arch Venture Fund VII, L.P.
Common Stock Acquisiton 2020-09-02 25,261 $0.00 60,109 No 4 J Indirect By Keith L.Crandall Trust
Common Stock Disposition 2020-09-02 220,641 $0.00 485,422 No 4 J Indirect By ARCH Venture Fund VIII Overage, L.P.
Common Stock Acquisiton 2020-09-02 3 $0.00 60,112 No 4 J Indirect By Keith L.Crandall Trust
Common Stock Disposition 2020-09-15 444,231 $0.00 780,546 No 4 J Indirect By Arch Venture Fund VII, L.P.
Common Stock Acquisiton 2020-09-15 22,578 $0.00 82,690 No 4 J Indirect By Keith L.Crandall Trust
Common Stock Disposition 2020-09-15 176,030 $0.00 309,392 No 4 J Indirect By ARCH Venture Fund VIII Overage, L.P.
Common Stock Acquisiton 2020-09-15 2 $0.00 82,692 No 4 J Indirect By Keith L.Crandall Trust
Common Stock Disposition 2020-12-07 53,712 $103.40 726,834 No 4 S Indirect By Arch Venture Fund VII, L.P.
Common Stock Disposition 2020-12-07 21,288 $103.40 288,104 No 4 S Indirect By ARCH Venture Fund VIII Overage, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect By Arch Venture Fund VII, L.P.
No 4 J Indirect By Keith L.Crandall Trust
No 4 J Indirect By ARCH Venture Fund VIII Overage, L.P.
No 4 J Indirect By Keith L.Crandall Trust
No 4 J Indirect By Arch Venture Fund VII, L.P.
No 4 J Indirect By Keith L.Crandall Trust
No 4 J Indirect By ARCH Venture Fund VIII Overage, L.P.
No 4 J Indirect By Keith L.Crandall Trust
No 4 J Indirect By Arch Venture Fund VII, L.P.
No 4 J Indirect By Keith L.Crandall Trust
No 4 J Indirect By ARCH Venture Fund VIII Overage, L.P.
No 4 J Indirect By Keith L.Crandall Trust
No 4 S Indirect By Arch Venture Fund VII, L.P.
No 4 S Indirect By ARCH Venture Fund VIII Overage, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,412 Direct
Footnotes
  1. Pro-rata distribution of Common Stock held by a limited partnership to its partners for no consideration.
  2. The shares are directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
  3. The shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("AVP GPLLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. AVP GPLLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
  4. Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
  5. Change in form of ownership of shares previously reported as beneficially owned by the reporting person.